MAtrix Therapy for Hard-to-heal ChrOnic Wounds
NCT: NCT05170984 · COMPLETED
Brief Summary
CACIPLIQ20® is currently a class III CE marked medical device available in various European and non-European countries, and currently primarily used in managing hard-to-heal wounds. This study is a prospective and standardized recording of patients' data followed in real-life conditions to appreciate the benefits of a therapeutic strategy including CACIPLIQ20® use. It also aims at collecting data to follow-up the device's efficacy and safety and estimate its cost-effectiveness.
Frequently Asked Questions
What is MAtrix Therapy for Hard-to-heal ChrOnic Wounds?
MAtrix Therapy for Hard-to-heal ChrOnic Wounds is a clinical trial registered under NCT05170984. Current status: COMPLETED.
What is the status of NCT05170984?
The current status of NCT05170984 (MAtrix Therapy for Hard-to-heal ChrOnic Wounds) is: COMPLETED.
When did MAtrix Therapy for Hard-to-heal ChrOnic Wounds start?
MAtrix Therapy for Hard-to-heal ChrOnic Wounds started on 2022-02-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.